tosufloxacin has been researched along with carbostyril in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.81) | 18.7374 |
| 1990's | 18 (66.67) | 18.2507 |
| 2000's | 3 (11.11) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aihara, M; Daimon, Y; Furuta, T; Honda, M; Kanno, H; Kubo, S; Oguri, T; Satoh, K; Sugawara, K; Yamanaka, K | 1 |
| Aubert, G; Dorche, G; Pozzetto, B | 3 |
| Chin, NX; Neu, HC | 2 |
| Bethune, L; King, A; Phillips, I | 1 |
| Bryan, JP; Krieg, RE; Perine, PL; Sheffield, J; Wagner, K; Waters, C | 1 |
| Matsumoto, F; Morita, M; Takahashi, T | 1 |
| Jehl, F; Koechlin, C; Linger, L; Monteil, H | 1 |
| Barry, AL; Jones, RN | 1 |
| Arakawa, S; Fujii, A; Kamidono, S; Maeda, H; Nakata, K | 1 |
| Fernandes, PB; Swanson, RN | 1 |
| Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
| Bauernfeind, A | 1 |
| Chan, CY; Cheng, AF; Cheung, SW; Lyon, DJ | 1 |
| Phillips, I; Power, EG | 1 |
| Nunome, M; Takahata, M; Yamashiro, Y; Yasuda, T | 1 |
| Mitsuhashi, S; Yoshida, T | 1 |
| Ibuki, E; Masuda, N; Miyoshi, H; Nishino, T; Otsuki, M; Takahashi, Y | 1 |
| Igarashi, H; Kawahara, M; Matsubara, N; Matsunaga, T; Narita, H; Oishi, Y; Onodera, S; Takahata, M; Watanabe, Y; Yonezawa, M | 1 |
| Hirayama, F; Ikeda, Y; Kawakita, T; Kuroda, T; Moriguchi, A; Sakurai, N; Sano, M; Uemori, S; Yamamoto, K | 1 |
| Araake, M; Hara, T; Nishino, T; Watabe, H | 1 |
| Akamine, M; Fujita, J; Haranaga, S; Higa, F; Koide, M; Saito, A; Shinzato, T; Tateyama, M; Tohyama, M | 1 |
| Hatou, S; Minagawa, Y; Yamada, M; Yoshida, J; Yoshida, T | 1 |
| Hara, N; Natsume, Y; Noguchi, N; Ochiai, S; Seyama, S; Shibata, M; Shirai, A; Shiro, H; Tanaka, E; Wajima, T | 1 |
| Adachi, Y; Iwata, S; Mokuno, E; Morozumi, M; Sakuma, M; Tajima, T; Ubukata, K | 1 |
27 other study(ies) available for tosufloxacin and carbostyril
| Article | Year |
|---|---|
[Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
Topics: Anti-Infective Agents; Bacteria; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Organizations; Quinolones; United States; World Health Organization | 1992 |
Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Topics: Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Naphthyridines; Norfloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 1992 |
In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones | 1991 |
The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin.
Topics: Anti-Infective Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Ciprofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1991 |
[In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
Topics: Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; In Vitro Techniques; Naphthyridines; Pefloxacin; Quinolones; Streptococcus; Streptococcus agalactiae; Streptococcus bovis; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus sanguis | 1991 |
[In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterococcus faecalis; Fluoroquinolones; Imipenem; In Vitro Techniques; Naphthyridines; Piperacillin; Quinolones | 1991 |
In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Diarrhea; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1990 |
[Therapeutic drug monitoring of fluoroquinolone].
Topics: Anti-Infective Agents; Bile; Biological Assay; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Naphthyridines; Norfloxacin; Ofloxacin; Quinolones; Sputum | 1990 |
High-performance liquid chromatography for the determination of three new fluoroquinolones, fleroxacin, temafloxacin and A-64730, in biological fluids.
Topics: Anti-Infective Agents; Bile; Chromatography, High Pressure Liquid; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Humans; Molecular Structure; Naphthyridines; Quinolones; Spectrometry, Fluorescence | 1989 |
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Fluoroquinolones; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Quinolones | 1989 |
In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains.
Topics: Anti-Infective Agents; Chlamydia; Ciprofloxacin; Fleroxacin; Fluoroquinolones; Naphthyridines; Quinolones | 1988 |
Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Enoxacin; Fleroxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Pefloxacin; Quinolones | 1988 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1993 |
Rapid HPLC assay of clinafloxacin, fleroxacin, levofloxacin, sparfloxacin and tosufloxacin.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Fleroxacin; Fluoroquinolones; Humans; Naphthyridines; Quinolones; Reproducibility of Results | 1994 |
In vitro activity of the new fluoroquinolone CP-99,219.
Topics: Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Quinolones | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
[Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bone and Bones; Fluoroquinolones; Haemophilus influenzae; Joints; Male; Microbial Sensitivity Tests; Naphthyridines; Quinolones; Rabbits; Staphylococcus aureus; Streptococcus pyogenes | 1993 |
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Dioxolanes; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Topoisomerase II Inhibitors | 1993 |
In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Drug Evaluation, Preclinical; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Mice; Naphthyridines; Piperazines; Pneumonia, Bacterial; Quinolones | 1996 |
Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
Topics: Anti-Infective Agents; Base Sequence; Coagulase; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Naphthyridines; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Staphylococcus; Staphylococcus epidermidis | 1997 |
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Drug Stability; Fluoroquinolones; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Indicators and Reagents; Microbial Sensitivity Tests; Molecular Structure; Naphthyridines; Ofloxacin; Quinolones; Solutions; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
Topics: Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dosage Forms; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fleroxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Prodrugs; Quinolones | 2002 |
In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Colony Count, Microbial; Fluoroquinolones; Legionella; Macrolides; Macrophages; Mice; Microbial Sensitivity Tests; Naphthyridines; Oxazines; Quinolones | 2005 |
Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones.
Topics: Aza Compounds; Conjunctiva; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, MDR; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Staphylococcus epidermidis | 2008 |
Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Child; Child, Preschool; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mutation; Naphthyridines; Quinolones; Young Adult | 2019 |
Genetic characteristics and antibiotic resistance of Haemophilus influenzae isolates from pediatric patients with acute otitis media after introduction of 13-valent pneumococcal conjugate vaccine in Japan.
Topics: Acute Disease; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Naphthyridines; Otitis Media; Pneumococcal Vaccines; Quinolones; Streptococcus pneumoniae; Vaccines, Conjugate | 2019 |